RxDoctor Payments Data

Allison Fischer, DPM

Podiatrist · Weston, WINPI 1588245955

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (35.4%), education and food and beverage — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Stryker at 40.6% of the total. Reporting peaked in 2022 at $2,463 and has fallen 50.4% since, to $1,220 in 2025.

$7,156in general payments, 2019–2025

Across 64 payments — averaging $111.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$3K
  • Gemini Mountain Medical, LLC$2K
  • Arthrex$766
  • True North Surgical Inc$475
  • Medline Industries LP$370
  • Smith+Nephew$151
  • plus $29 from 1 others

What the payments were for

  • Travel & lodging$2,53035%
  • Food & beverage$2,22631%
  • Education$2,40034%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Stryker33$2,908
Gemini Mountain Medical, LLC4$2,458
Arthrex8$766
True North Surgical Inc6$475
Medline Industries LP8$370
Smith+Nephew3$151
Johnson & Johnson2$29

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,156 in reported general payments places this provider in the 85th percentile of 140 podiatrist providers in Wisconsin.

See all podiatrist providers in Wisconsin

Medicare billing

Part B allowed, 2024
$37,301
Medicare patients
306
Services billed
888

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone18$97

Paid to pharmacies, not to this prescriber.

Other podiatrist in Weston

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →